Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak

BMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7048.46a (Published 06 July 1996) Cite this as: BMJ 1996;313:46
  1. Graham Worrall
  1. Director Centre for Rural Health Studies, Memorial University of Newfoundland, Whitbourne, Newfoundland, Canada AOB 3KO

    EDITOR,—In a letter responding to my editorial about the value of acyclovir in recurrent herpes labialis1 P-J Lamey says that the benefit of topical acyclovir has never been truly evaluated.2 I agree. In my critical appraisal of …

    View Full Text

    Sign in

    Log in through your institution